Technology News and Research

RSS

Kyto Biopharma signs licensing agreement with RFSUNY, gains patent rights to Transcobalamin Receptor

Kyto Biopharma Inc., is pleased to announce that it has signed a licensing agreement with the Research Foundation of the State University of New York. The licensing agreement grants Kyto patent rights to the Transcobalamin (Vitamin B12) Receptor and to an additional broad group of other patents which are critical to Kyto’s research and development strategy for the treatment of cancer.

5 Mar 2010

Proper diagnosis, treatment and good skin care help control acne and rosacea

Acne and rosacea are two seemingly different skin conditions that have one important thing in common: both are chronic and extremely common skin conditions. However, dermatologists recommend that with proper diagnosis, treatment and a healthy dose of good, old-fashioned skin care, acne and rosacea can be less of a nuisance for patients.

5 Mar 2010

MED3OOO, Acryness announce strategic partnership to provide QuikBill patient billing solutions

MED3OOO, a leading healthcare management and technology company, and Acryness, a document processing and mailing organization, announce a strategic partnership to provide patient-friendly and intelligent content-driven statement solutions. The partnership will provide the MED3OOO QuikBill patient billing solutions, powered by Acryness, to MED3OOO's Revenue Cycle Management and ASP Practice Management clients.

5 Mar 2010

Argos Therapeutics' AGS-004 immunotherapy for HIV demonstrates clinical and commercial potential

Argos Therapeutics today announced the publication of a manuscript in the February edition of Clinical Immunology, detailing positive immune response, safety and manufacturing data for its AGS-004 immunotherapy for HIV. AGS-004 is a product of the Company’s Arcelis™ technology, and is a personalized, RNA-loaded dendritic cell-based immunotherapy that is perfectly matched to each patient’s unique HIV viral burden. The manuscript details a clinical study in which AGS-004 was evaluated in type-1 HIV-infected adults who were being treated with antiretroviral therapy (ART).

5 Mar 2010

Vaxart raises $12.5M to advance Phase I clinical trials on Avian flu vaccine

Vaxart, Inc., a San Francisco biotechnology company developing oral-delivery vaccines, has closed a $12.5 million Series B financing, led by Care Capital of Princeton NJ. The funding will be used to advance the Company's lead product, an oral vaccine for Avian influenza, through Phase I clinical trials.

4 Mar 2010

Evaluating bone defect repairs using human stem cells: NeoStem, University of Michigan enter into SRA

NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced today that it has entered into a sponsored research agreement (SRA) with the University of Michigan to evaluate bone defect repairs using human stem cells. The one-year project, beginning in March, will be funded through the proceeds of a $108,746 grant from the National Institutes of Health (NIH) under the Small Business Innovative Research Program (SBIR).

4 Mar 2010

AB SCIEX collaborates with Mass Spectrometry Centre to improve drug discovery and development

AB SCIEX, a global leader in life science analytical technologies, today announced that it is collaborating with the University of Geneva’s Mass Spectrometry Centre to create new workflows and analytical strategies intended to significantly improve drug discovery and development.

4 Mar 2010

Watson Pharmaceuticals to acquire U.S. rights to Columbia's bioadhesive progesterone gel products

Watson Pharmaceuticals, Inc. today announced an agreement to expand their Women's Health brand product portfolio with the acquisition of the exclusive U.S. rights to Columbia Laboratories, Inc.'s bioadhesive progesterone gel products currently marketed under the trade names CRINONE® and PROCHIEVE® for the indications of infertility and secondary amenorrhea.

4 Mar 2010

Top ten beauty treatments

RoxSpa, one of the most prestigious and luxurious medi-spas in Beverly Hills, announces their annual 'Top Ten' face and body rejuvenation treatments that are both highly-effective and provide the most satisfying results.

4 Mar 2010

SXC Health Solutions reports 2009 financial results

SXC Health Solutions Corp., announces its financial results for the three- and twelve-month periods ended December 31, 2009. Financial references are in U.S. dollars unless otherwise indicated.

4 Mar 2010

Valley Presbyterian Hospital announces opening of premier Amputation Prevention Center

Valley Presbyterian Hospital is proud to announce the planned red-carpet grand-opening on March 17th of its premier Amputation Prevention Center (APC), an integrated limb-preservation center that is one of the nation’s only facilities of its kind.

4 Mar 2010

Study indicates personality does not influence career decisions

Researchers from the University of C-diz (UCA) have studied the connection between professional preferences and personality, based on interviews and questionnaires carried out on 735 secondary school students from the province of Cadiz. The results indicate that personality does not have an influence when choosing a professional career.

4 Mar 2010

Alnylam Pharmaceuticals asks Court to dismiss MIT from any claims for monetary damages in ongoing litigation

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the company and Max Planck have asked the Court to dismiss the Massachusetts Institute of Technology from any claims for monetary damages in the ongoing litigation related to the Tuschl I patent series.

4 Mar 2010

SXC Health Solutions and HealthSpring sign PBM contract

SXC Health Solutions Corp., a leading provider of pharmacy benefit management (PBM) products and services, today announced that its informedRx PBM unit has been awarded a contract with HealthSpring Inc.

4 Mar 2010

Atacama Labs and Excella partner to sell PDG Granule and Tablet Manufacturing Services

Atacama Labs Oy has developed an innovative oral drug delivery technology (called 'pneumatic dry granulation' or 'PDG Technology(TM)'). The technology is aimed to replace existing solid dosage form development and manufacturing methods (like wet granulation or standard roller compaction) and will help both NCE galenic developers and life cycle managers to overcome development or differentiation issues.

4 Mar 2010

Move from paper to EMR: Time to start making the switch is now

The prospect of the U.S. healthcare system moving from paper to electronic medical records (EMR) has given rise to a host of thorny questions on matters of privacy, security, logistics and more. But according to EMR attorneys at the national law firm of LeClairRyan, the time to start making the switch is now–in part because the federal government will soon finalize important new guidelines on what healthcare providers need to do in order to "go digital."

4 Mar 2010

MIT Technology Review recognizes Medtronic for taking leadership in developing DBS Therapy

Medtronic, Inc. today announced that it has been selected as one of Massachusetts Institute of Technology Technology Review's 50 most innovative companies. Known as TR50, the first annual list includes companies that Technology Review believes have demonstrated superiority in inventing technology and in using it both to grow their own business and transform how we live.

4 Mar 2010

Covidien enters into preferred vendor partnership with OSF Healthcare System

Covidien, a leading global provider of healthcare products and recognized innovator of mechanical ventilation and respiratory care devices, today announced it has entered into a long-term, preferred vendor partnership with the Order of Saint Francis (OSF) Healthcare System, headquartered in Peoria, Ill. After using a mix of SPO2 technologies for more than eight years, the OSF Healthcare System recently standardized to OxiMax™ technology for all its pulse oximetry needs.

4 Mar 2010

Project ProSPECTus develops technology for next generation SPECT imaging to improve diagnosis of cancer

Time taken to detect brain tumours could soon be significantly reduced thanks to an ongoing pioneering project led by the University of Liverpool with the Nuclear Physics Group and Technology departments at the Science and Technology Facilities Council (STFC) at Daresbury Laboratory.

4 Mar 2010

OSMA expands preferred partner agreement with NextGen Healthcare Information Systems

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and leading provider of healthcare information systems and connectivity solutions, today announced that the Ohio State Medical Association has expanded its preferred partner agreement with the company.

4 Mar 2010

Technology News and Research

Kyto Biopharma signs licensing agreement with RFSUNY, gains patent rights to Transcobalamin Receptor

Proper diagnosis, treatment and good skin care help control acne and rosacea

MED3OOO, Acryness announce strategic partnership to provide QuikBill patient billing solutions

Argos Therapeutics' AGS-004 immunotherapy for HIV demonstrates clinical and commercial potential

Vaxart raises $12.5M to advance Phase I clinical trials on Avian flu vaccine

Evaluating bone defect repairs using human stem cells: NeoStem, University of Michigan enter into SRA

AB SCIEX collaborates with Mass Spectrometry Centre to improve drug discovery and development

Watson Pharmaceuticals to acquire U.S. rights to Columbia's bioadhesive progesterone gel products

Top ten beauty treatments

SXC Health Solutions reports 2009 financial results

Valley Presbyterian Hospital announces opening of premier Amputation Prevention Center

Study indicates personality does not influence career decisions

Alnylam Pharmaceuticals asks Court to dismiss MIT from any claims for monetary damages in ongoing litigation

SXC Health Solutions and HealthSpring sign PBM contract

Atacama Labs and Excella partner to sell PDG Granule and Tablet Manufacturing Services

Move from paper to EMR: Time to start making the switch is now

MIT Technology Review recognizes Medtronic for taking leadership in developing DBS Therapy

Covidien enters into preferred vendor partnership with OSF Healthcare System

Project ProSPECTus develops technology for next generation SPECT imaging to improve diagnosis of cancer

OSMA expands preferred partner agreement with NextGen Healthcare Information Systems

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News